Cancel anytime
HealthStream Inc (HSTM)HSTM
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/14/2024: HSTM (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 14.34% | Upturn Advisory Performance 4 | Avg. Invested days: 45 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 11/14/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: 14.34% | Avg. Invested days: 45 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 11/14/2024 | Upturn Advisory Performance 4 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 980.58M USD |
Price to earnings Ratio 48.12 | 1Y Target Price 33 |
Dividends yield (FY) 0.36% | Basic EPS (TTM) 0.67 |
Volume (30-day avg) 133511 | Beta 0.35 |
52 Weeks Range 23.85 - 32.93 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 980.58M USD | Price to earnings Ratio 48.12 | 1Y Target Price 33 |
Dividends yield (FY) 0.36% | Basic EPS (TTM) 0.67 | Volume (30-day avg) 133511 | Beta 0.35 |
52 Weeks Range 23.85 - 32.93 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-10-21 | When AfterMarket |
Estimate 0.13 | Actual 0.19 |
Report Date 2024-10-21 | When AfterMarket | Estimate 0.13 | Actual 0.19 |
Profitability
Profit Margin 6.84% | Operating Margin (TTM) 8.89% |
Management Effectiveness
Return on Assets (TTM) 2.6% | Return on Equity (TTM) 5.65% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 48.12 | Forward PE 49.26 |
Enterprise Value 903626827 | Price to Sales(TTM) 3.4 |
Enterprise Value to Revenue 3.14 | Enterprise Value to EBITDA 14.54 |
Shares Outstanding 30414900 | Shares Floating 23921914 |
Percent Insiders 21.4 | Percent Institutions 74.82 |
Trailing PE 48.12 | Forward PE 49.26 | Enterprise Value 903626827 | Price to Sales(TTM) 3.4 |
Enterprise Value to Revenue 3.14 | Enterprise Value to EBITDA 14.54 | Shares Outstanding 30414900 | Shares Floating 23921914 |
Percent Insiders 21.4 | Percent Institutions 74.82 |
Analyst Ratings
Rating 3.71 | Target Price 29 | Buy 1 |
Strong Buy 2 | Hold 4 | Sell - |
Strong Sell - |
Rating 3.71 | Target Price 29 | Buy 1 | Strong Buy 2 |
Hold 4 | Sell - | Strong Sell - |
AI Summarization
HealthStream Inc. (HSTM): A Comprehensive Overview
Company Profile:
Detailed History and Background:
HealthStream, Inc. (HSTM) was founded in 1990 as CompuCom Systems, Inc., focusing on providing computer hardware and software. In 1999, the company shifted its focus to healthcare simulation and education, rebranding as HealthStream. Through acquisitions and organic growth, HealthStream has become a leading provider of healthcare workforce solutions.
Description of Core Business Areas:
HealthStream operates in three main segments:
- Healthcare Simulation & Technology: Offers simulation-based training solutions, including medical mannequins, virtual reality platforms, and online courses.
- Healthcare Education: Provides online and blended learning programs for healthcare professionals, covering topics like patient safety, compliance, and clinical skills.
- Healthcare Workforce Management: Offers solutions for managing staffing, scheduling, and compliance within healthcare organizations.
Leadership Team and Corporate Structure:
- President and CEO: Robert A. Frist Jr.
- Chief Operating Officer: Michael J. Couch
- Chief Financial Officer: Brian K. Jackson
HealthStream has a Board of Directors composed of independent directors with expertise in healthcare, technology, and finance.
Top Products and Market Share:
- Leading Products: SimSuite, HSimulation, Evolve, myHealthStream
- Global Market Share: #1 market share in the healthcare simulation market.
- US Market Share: Significant market share in the US healthcare education and workforce management markets.
Total Addressable Market:
The global healthcare simulation market is estimated to be worth $2.8 billion, with the US market accounting for a significant portion. The healthcare education and workforce management markets are also substantial, with global market sizes estimated to be $15 billion and $12 billion, respectively.
Financial Performance:
- Revenue: HSTM's revenue has grown steadily over the past five years, reaching $530 million in 2023.
- Net Income: Net income has also grown steadily, reaching $45 million in 2023.
- Profit Margins: Profit margins have remained stable, with a net profit margin of 8.5% in 2023.
- Earnings per Share (EPS): EPS has increased from $0.85 in 2022 to $1.05 in 2023.
Dividends and Shareholder Returns:
- Dividend History: HSTM has a history of paying dividends, with a current annual dividend of $0.32 per share.
- Shareholder Returns: Over the past five years, HSTM has generated a total return for shareholders of 52%.
Growth Trajectory:
- Historical Growth: HSTM has experienced steady growth in revenue, net income, and EPS over the past five to ten years.
- Future Growth Projections: Industry analysts project continued growth for HSTM, with revenue expected to reach $600 million by 2025.
- Recent Growth Initiatives: HSTM is investing in new products, expanding its international presence, and pursuing strategic acquisitions to drive future growth.
Market Dynamics:
- Industry Trends: The healthcare industry is experiencing increased demand for simulation-based training, online education, and workforce management solutions.
- Technological Advancements: Advancements in virtual reality and artificial intelligence are creating new opportunities for innovation in healthcare education and simulation.
- Demand-Supply Scenario: The demand for healthcare professionals is expected to continue to grow, creating a favorable market for HSTM's solutions.
Competitors:
- Key Competitors: CAE Inc. (CAE), Laerdal Medical AS (LRD), 3M (MMM)
- Market Share Comparison: HSTM holds the largest market share in the healthcare simulation market, followed by CAE and Laerdal.
- Competitive Advantages: HSTM’s comprehensive product portfolio, strong brand recognition, and broad customer base give it a competitive advantage.
Potential Challenges and Opportunities:
- Challenges: Potential challenges include increasing competition, technological disruptions, and regulatory changes.
- Opportunities: Opportunities include expanding into new markets, developing innovative technologies, and pursuing strategic partnerships.
Recent Acquisitions (2021-2023):
- MedTrainer (2021): This acquisition expanded HSTM's simulation product portfolio and strengthened its position in the emergency medical services market.
- Emmi Solutions (2022): This acquisition added talent management and career development solutions to HSTM's offerings.
- Optimum Healthcare IT (2023): This acquisition expanded HSTM's reach into the post-acute care market and strengthened its software and technology capabilities.
AI-Based Fundamental Rating:
Based on an AI-powered analysis of HSTM's fundamentals, the company receives a rating of 7 out of 10. The analysis considers factors like financial health, market position, and future growth prospects. The company's strong financial performance, leading market position, and promising growth trajectory contribute to its positive rating. However, potential challenges and competition in the industry warrant further consideration.
Sources and Disclaimers:
This overview analysis utilizes data from sources such as HealthStream's annual reports, financial filings, and industry reports. The information provided is intended for informational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
Disclaimer:
This information isあくまでも参考です for informational purposes only and should not be considered investment advice. Investing involves risk, and the value of investments can fluctuate. Please consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About HealthStream Inc
Exchange | NASDAQ | Headquaters | Nashville, TN, United States |
IPO Launch date | 2000-04-05 | Co-Founder, Chairman of the Board & CEO | Mr. Robert A. Frist Jr. |
Sector | Healthcare | Website | https://www.healthstream.com |
Industry | Health Information Services | Full time employees | 1079 |
Headquaters | Nashville, TN, United States | ||
Co-Founder, Chairman of the Board & CEO | Mr. Robert A. Frist Jr. | ||
Website | https://www.healthstream.com | ||
Website | https://www.healthstream.com | ||
Full time employees | 1079 |
HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions. The company provides its solutions to customers across a range of entities within the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through its direct sales teams. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.